A detailed history of Guyasuta Investment Advisors Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 68,075 shares of MRK stock, worth $7.73 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
68,075
Previous 68,075 -0.0%
Holding current value
$7.73 Million
Previous $8.98 Million 6.18%
% of portfolio
0.58%
Previous 0.61%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$100.18 - $109.02 $110,698 - $120,467
-1,105 Reduced 1.6%
68,075 $7.42 Million
Q3 2023

Oct 25, 2023

SELL
$102.95 - $114.33 $110,156 - $122,333
-1,070 Reduced 1.52%
69,180 $7.12 Million
Q2 2023

Jul 17, 2023

SELL
$108.61 - $118.38 $414,347 - $451,619
-3,815 Reduced 5.15%
70,250 $8.11 Million
Q1 2023

Apr 28, 2023

SELL
$102.94 - $114.86 $231,820 - $258,664
-2,252 Reduced 2.95%
74,065 $7.88 Million
Q4 2022

Jan 30, 2023

BUY
$87.44 - $112.11 $191,318 - $245,296
2,188 Added 2.95%
76,317 $8.47 Million
Q3 2022

Oct 25, 2022

BUY
$84.53 - $94.96 $53,253 - $59,824
630 Added 0.86%
74,129 $6.38 Million
Q2 2022

Jul 21, 2022

BUY
$83.49 - $94.64 $5,426 - $6,151
65 Added 0.09%
73,499 $6.7 Million
Q1 2022

May 03, 2022

SELL
$73.51 - $82.4 $13,599 - $15,244
-185 Reduced 0.25%
73,434 $6.03 Million
Q4 2021

Feb 08, 2022

SELL
$72.28 - $90.54 $235,271 - $294,707
-3,255 Reduced 4.23%
73,619 $5.64 Million
Q3 2021

Nov 09, 2021

BUY
$71.68 - $78.83 $98,129 - $107,918
1,369 Added 1.81%
76,874 $5.77 Million
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $235,890 - $260,918
3,355 Added 4.65%
75,505 $5.87 Million
Q1 2021

May 11, 2021

SELL
$68.86 - $81.11 $337,827 - $397,925
-4,906 Reduced 6.37%
72,150 $5.56 Million
Q4 2020

Feb 08, 2021

BUY
$71.77 - $79.65 $12,559 - $13,938
175 Added 0.23%
77,056 $6.3 Million
Q3 2020

Oct 28, 2020

BUY
$73.18 - $82.95 $293,232 - $332,380
4,007 Added 5.5%
76,881 $6.38 Million
Q2 2020

Aug 06, 2020

BUY
$70.42 - $80.13 $101,756 - $115,787
1,445 Added 2.02%
72,874 $5.64 Million
Q1 2020

Apr 28, 2020

BUY
$63.36 - $87.82 $217,578 - $301,573
3,434 Added 5.05%
71,429 $5.5 Million
Q4 2019

Feb 10, 2020

SELL
$77.58 - $87.54 $47,246 - $53,311
-609 Reduced 0.89%
67,995 $6.18 Million
Q3 2019

Nov 08, 2019

SELL
$76.08 - $82.93 $190,428 - $207,573
-2,503 Reduced 3.52%
68,604 $5.51 Million
Q2 2019

Aug 06, 2019

BUY
$69.84 - $81.59 $188,917 - $220,700
2,705 Added 3.95%
71,107 $5.96 Million
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $20,874 - $23,808
-300 Reduced 0.44%
68,402 $5.69 Million
Q4 2018

Feb 11, 2019

SELL
$65.24 - $75.71 $150,052 - $174,133
-2,300 Reduced 3.24%
68,702 $5.25 Million
Q3 2018

Nov 08, 2018

SELL
$57.69 - $67.84 $57,170 - $67,229
-991 Reduced 1.38%
71,002 $5.04 Million
Q2 2018

Aug 07, 2018

SELL
$50.83 - $59.72 $85,292 - $100,210
-1,678 Reduced 2.28%
71,993 $4.37 Million
Q1 2018

May 09, 2018

BUY
$50.96 - $59.23 $445,237 - $517,492
8,737 Added 13.46%
73,671 $4.01 Million
Q4 2017

Feb 12, 2018

SELL
$51.62 - $61.64 $228,212 - $272,510
-4,421 Reduced 6.37%
64,934 $3.65 Million
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $56,323 - $60,604
960 Added 1.4%
69,355 $4.44 Million
Q2 2017

Aug 09, 2017

BUY
N/A
68,395
68,395 $4.38 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Guyasuta Investment Advisors Inc Portfolio

Follow Guyasuta Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.